Article tools
Author information
Published in Volume 99, Issue 10 (May 15,1997)
J. Clin. Invest. 99(10): 2538-2544 (1997). doi:10.1172/JCI119438.
Copyright © 1997, The American Society for Clinical Investigation

Research Article

Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.

G Di Cola, M H Cool and D Accili

Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

Published May 15, 1997

We have investigated the metabolic actions of recombinant human IGF-1 in mice genetically deficient of insulin receptors (IR-/-). After intraperitoneal administration, IGF-1 caused a prompt and sustained decrease of plasma glucose levels in IR-/- mice. Plasma free fatty acid concentrations were unaffected. Interestingly, the effects of IGF-1 were identical in normal mice (IR+/+) and in IR-/- mice. Despite decreased glucose levels, IR-/- mice treated with IGF-1 died within 2-3 d of birth, like sham-treated IR-/- controls. In skeletal muscle, IGF-1 treatment caused phosphorylation of IGF-1 receptors and increased the levels of the phosphatidylinositol-3-kinase p85 subunit detected in antiphosphotyrosine immunoprecipitates, consistent with the possibility that IGF-1 stimulates glucose uptake in a phosphatidylinositol-3-kinase-dependent manner. IGF-1 receptor phosphorylation and coimmunoprecipitation of phosphatidylinositol3-kinase by antiphosphotyrosine antibodies was also observed in liver, and was associated with a decrease in mRNA levels of the key gluconeogenetic enzyme phosphoenolpyruvate carboxykinase. Thus, the effect of IGF-1 on plasma glucose levels may be accounted for by increased peripheral glucose use and by inhibition of hepatic gluconeogenesis. These data indicate that IGF-1 can mimic insulin's effects on glucose metabolism by acting through its own receptor. The failure of IGF-1 to rescue the lethal phenotype due to lack of insulin receptors suggests that IGF-1 receptors cannot effectively mediate all the metabolic actions of insulin receptors.

This article Copyright © 1997, The American Society for Clinical Investigation.

Articles that cite this article:

The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression
Jun Nakae, Tadahiro Kitamura, David L. Silver, Domenico Accili
J Clin Invest 108(9):1359. doi:10.1172/JCI12876 [CrossRef]

Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor
Shouhong Xuan, Tadahiro Kitamura, Jun Nakae, Katerina Politi, Yoshiaki Kido, Peter E. Fisher, Manrico Morroni, Saverio Cinti, Morris F. White, Pedro L. Herrera
J Clin Invest 110(7):1011. doi:10.1172/JCI15276 [CrossRef]

The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis
R. I. G. Holt, H. L. Simpson, P. H. Sonksen
Diabetic Med 20(1):3. doi:10.1046/j.1464-5491.2003.00827.x [CrossRef]

Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation
Lorraine Yau, Helena Lukes, Heather Mcdiarmid, Julieta Werner, Peter Zahradka
Eur J Biochem 266(3):1147. doi:10.1046/j.1432-1327.1999.00968.x [CrossRef]

Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients
Soji Kasayama, Michio Otsuki, Miki Takagi, Hiroshi Saito, Satoru Sumitani, Haruhiko Kouhara, Masafumi Koga, Youichi Saitoh, Takanori Ohnishi, Norio Arita
Clin Endocrinol (Oxf) 52(5):549. doi:10.1046/j.1365-2265.2000.00986.x [CrossRef]

INSULIN RECEPTOR KNOCKOUT MICE
Tadahiro Kitamura, C. Ronald Kahn, Domenico Accili
Annu Rev Physiol 65(1):313. doi:10.1146/annurev.physiol.65.092101.142540 [CrossRef]

Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development
S P Sébert, G Lecannu, F Kozlowski, B Siliart, J M Bard, M Krempf, M M -J Champ
Int J Obes 29(3):324. doi:10.1038/sj.ijo.0802823 [CrossRef]

TRANSGENIC MICE IN THE ANALYSIS OF METABOLIC REGULATION
Fatima Bosch, Anna Pujol, Alfons Valera
Annu Rev Nutr 18(1):207. doi:10.1146/annurev.nutr.18.1.207 [CrossRef]

Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1
Derek Leroith, Shoshana Yakar
Nat Clin Pract Endocrinol Metab 3(3):302. doi:10.1038/ncpendmet0427 [CrossRef]

Cathepsin L activity controls adipogenesis and glucose tolerance
Min Yang, Yaou Zhang, Jiehong Pan, Jiusong Sun, Jian Liu, Peter Libby, Galina K. Sukhova, Alessandro Doria, Nobuhiko Katunuma, Odile D. Peroni
Nat Cell Biol 9(8):978. doi:10.1038/ncb1623 [CrossRef]

Regulation of Breast Cancer Metastasis by IGF Signaling
Deepali Sachdev
J Mammary Gland Biol Neoplasia 13(4):431. doi:10.1007/s10911-008-9105-5 [CrossRef]

Beneficial effect of insulin-like growth factor-1 on hypoxemic renal dysfunction in the newborn rabbit
Anne Prévot, Monique Julita, David K. Tung, Dolores Mosig
Pediatr Nephrol 24(5):973. doi:10.1007/s00467-008-1098-1 [CrossRef]